Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1978 1
1979 2
1980 1
1992 1
1999 3
2000 1
2001 1
2002 4
2003 4
2004 4
2005 3
2006 4
2007 4
2008 9
2009 6
2010 13
2011 5
2012 8
2013 10
2014 15
2015 11
2016 13
2017 11
2018 16
2019 9
2020 16
2021 22
2022 19
2023 23
2024 15
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Results by year

Filters applied: . Clear all
Page 1
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.
Vergote I, González-Martín A, Fujiwara K, Kalbacher E, Bagaméri A, Ghamande S, Lee JY, Banerjee S, Maluf FC, Lorusso D, Yonemori K, Van Nieuwenhuysen E, Manso L, Woelber L, Westermann A, Covens A, Hasegawa K, Kim BG, Raimondo M, Bjurberg M, Cruz FM, Angelergues A, Cibula D, Barraclough L, Oaknin A, Gennigens C, Nicacio L, Teng MSL, Whalley E, Soumaoro I, Slomovitz BM; innovaTV 301/ENGOT-cx12/GOG-3057 Collaborators. Vergote I, et al. N Engl J Med. 2024 Jul 4;391(1):44-55. doi: 10.1056/NEJMoa2313811. N Engl J Med. 2024. PMID: 38959480 Clinical Trial.
Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD)-European Society of Gynaecologic Oncology (ESGO)-Gynecologic Cancer InterGroup (GCIG)-International Society for the Study of Trophoblastic Diseases (ISSTD).
Lok C, van Trommel N, Braicu EI, Planchamp F, Berkowitz R, Seckl M; EOTTD-ESGO-GCIG-ISSTD Guideline Committee. Lok C, et al. J Clin Oncol. 2025 Jun 20;43(18):2119-2128. doi: 10.1200/JCO-24-02326. Epub 2025 May 13. J Clin Oncol. 2025. PMID: 40359461
Hypohidrosis in children.
Leung AK, Cho HY, Choi MC, Chan PY. Leung AK, et al. Among authors: choi mc. J R Soc Promot Health. 1999 Jun;119(2):101-7. doi: 10.1177/146642409911900208. J R Soc Promot Health. 1999. PMID: 11043004 Review.
Antitumor Effects of Selenium.
Kim SJ, Choi MC, Park JM, Chung AS. Kim SJ, et al. Among authors: choi mc. Int J Mol Sci. 2021 Oct 31;22(21):11844. doi: 10.3390/ijms222111844. Int J Mol Sci. 2021. PMID: 34769276 Free PMC article. Review.
Hyperhidrosis.
Leung AK, Chan PY, Choi MC. Leung AK, et al. Among authors: choi mc. Int J Dermatol. 1999 Aug;38(8):561-7. doi: 10.1046/j.1365-4362.1999.00609.x. Int J Dermatol. 1999. PMID: 10487442 Review. No abstract available.
Unusual grafts for living-donor liver transplantation.
Yim SH, Min EK, Choi MC, Kim DG, Han DH, Joo DJ, Choi JS, Kim MS, Choi GH, Lee JG. Yim SH, et al. Among authors: choi mc. Eur J Med Res. 2023 Oct 24;28(1):454. doi: 10.1186/s40001-023-01428-5. Eur J Med Res. 2023. PMID: 37875961 Free PMC article.
251 results